Saudi German Health
السعودي الألماني الصحيةTechnical Analysis & Signals
The Saudi German Health stock shows positive signals with a potential upward trend.
Technical Analysis
The stock is currently trading at SAR 34.94, with the RSI at 61.9, indicating positive momentum. Additionally, it shows a bullish divergence and an ascending triangle pattern, suggesting a potential continuation of the upward trend.
Support & Resistance Levels
The main support level is SAR 34.7, while resistance is at SAR 35.28. The stock is expected to react to these levels, which may influence its direction in the upcoming period.
Volume Analysis
The current trading volume indicates moderate activity, which may reflect investor interest. If the volume continues to increase, it could strengthen the stock's upward trend.
Fundamental Factors
The current stock price reflects a P/E ratio of 8.6 and a dividend yield of 1.44%. These factors indicate a relatively attractive valuation, which may attract investors under current economic conditions.
Risk Factors
The company may face challenges related to fluctuations in the Saudi market, along with general economic risks. Investors should be aware of these risks before making any investment decisions.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. Investors are advised to conduct their own research and review their strategies before making any decisions.
Automated analysis is based on historical data and technical indicators and may not reflect future market conditions.
Financial Fundamentals
Price Data
Price Chart - Saudi German Health
4009Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Weak TrendFinancial Summary
Valuation
- Market Cap
- 3.22B
- P/E Ratio
- 8.60
- P/B Ratio
- 1.70
- EPS (Earnings/Share)
- 4.08
Profitability
- Revenue
- 3.10B
- Net Income
- 301.88M
- Return on Equity (ROE)
- +20.00%
- Shares Outstanding
- 92.04M
Balance Sheet
- Total Assets
- N/A
- Total Debt
- 2.54B
- Debt/Equity
- 1.32
- Free Float %
- +44.3%
Dividends & Margins
- Dividend Yield
- +1.44%
- Dividend/Share
- 0.50
- Book Value
- 20.55
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
4 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2024 | 2.88B +8.7% | 282.00M +1555.1% | 5.13B -0.2% | 2.47B -0.8% | 3.06 +1510.5% |
| 2023 | 2.65B +23.3% | 17.04M -77.3% | 5.13B +14.1% | 2.49B +10.9% | 0.19 -76.8% |
| 2022 | 2.15B +14.9% | 75.18M +337.1% | 4.50B +13.2% | 2.24B +13.9% | 0.82 +331.6% |
| 2021 | 1.87B | 17.20M | 3.97B | 1.97B | 0.19 |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
Saudi German Health launches ops at outpatient clinic complex in Riyadh
Saudi German Health sees revenue growth in 2026, margins to improve slightly: CEO
Saudi German Health board recommends buyback of up to 4.6M shares
Saudi German Health appoints Nezar Bahabri as CEO
AlJazira Capital issues Q4 2025 profit forecasts
SNB Capital sets Q4 2025 earnings estimates
Saudi German Health: A deep dive into Q4 2025 results
Saudi healthcare sector in Q4 2025: Key events likely to impact performance
News source: Argaam (argaam.com)
Sector Comparison
| Symbol | Name | Price | Change% |
|---|---|---|---|
| 4013 | Dr. Sulaiman Al Habib | 249.10 SAR | |
| 4002 | Mouwasat | 71.10 SAR | |
| 4004 | Dallah Healthcare | 124.60 SAR | |
| 4017 | Fakeeh Care | 32.40 SAR | |
| 4018 | Almoosa | 137.10 SAR | |
| 4005 | CARE | 130.70 SAR | |
| 4019 | SMC Healthcare | 17.70 SAR | |
| 4007 | Alhammadi | 25.72 SAR |
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-03-26
Risk Assessment
Risk Factors
Average True Range 7.4% of stock price
Trading volume near or above average
P/E ratio 8.6 — below average
Debt-to-equity ratio 1.32
ADX indicator at 16 — no clear direction
Stable fundamentals, low volatility, and good financial solvency
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is Saudi German Health stock price today?
Saudi German Health (4009) stock price today is 34.94 SAR, gaining by +0.69% compared to the previous session close. The 52-week price range is between 28.66 SAR and 71.18 SAR.
2 What is Saudi German Health stock valuation?
The automated analysis signal for Saudi German Health is "Buy" with 75% confidence. The P/E ratio is 8.6. The P/B ratio is 1.70.
3 Is Saudi German Health Shariah-compliant?
Yes, Saudi German Health (4009) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are Saudi German Health dividend distributions?
Saudi German Health has a dividend yield of 1.44%, with an estimated annual dividend of 0.50 SAR per share.
5 What is Saudi German Health weekly performance?
Saudi German Health performance over different time periods: weekly change +8.51%, monthly +1.10%, and year-to-date +6.01%. The stock is currently trading with a volume of 767,736 shares.
6 What is the target level for Saudi German Health?
According to automated analysis for Saudi German Health: Short-term target (1-2 weeks): 36.50 SAR. Medium-term target (1-3 months): 40.00 SAR. Support level: 34.70 SAR. Resistance level: 35.28 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.